Product Images Xofluza
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Xofluza NDC 50242-860 by Genentech, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - xofluza 01
Chemical Structure - xofluza 02
Chemical Structure - xofluza 03
Xofluza® is an oral suspension medication containing 2 mg baloxavir marboxil per mL after constitution, with a total usable volume of 20mL. It is taken as a single one-time dose and should be used before the suspension expires. There are no preservatives in the medication, and the appropriate measuring device should be used to ensure the correct total prescribed dose. Any unused portion should be discarded.*
PRINCIPAL DISPLAY PANEL - 2x20 mg tablets (40 mg single dose) - xofluza 04
Xofluza® is a medication available in tablet form containing 40mg of baloxavir marboxil. It is typically administered as a single, one-time dose. The National Drug Code (NDC) for Xofluza® is 50242-860-01. The instructions recommend taking the tablet from this package. However, the meaning of "ROHW, Lift Here H, Genentech 3" is not clear from this text.*
PRINCIPAL DISPLAY PANEL - 2x40 mg tablets (80 mg single dose) - xofluza 05
Xofluza® is a medication in tablet form with a total dose of 80mg per tablet. The usual method of consumption involves taking a single, one-time dose after opening the package. The medication is manufactured by Genentech and is available under NDC 50242-877-01.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.